Drugs / beclomethasone HFA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00200967 Background | Dec 2004 → Feb 2008 | asthma | Milton S. Hershey Medical Center | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | beclomethasone HFA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00200967 ↗ |
| Route | Inhaled | “Open-label inhaled corticosteroid (hydrofluoroalkane beclometasone 240 microg twice a day) was given to all participants during the treatment periods.” PMID 19932356 ↗ Nov 2009 |